2 approved drugs show promise in treating prion disease

04/4/2013 | Yahoo

Researchers have found that two drugs already approved for use in humans -- tacrolimus and astemizole -- reduce the amount of prion protein present on cell surfaces by about 70%. Misfolded forms of the proteins are believed to cause such diseases as Creutzfeldt-Jakob disease. Astemizole is the most promising because it is effective at relatively low doses, while tacrolimus can cause neurotoxicity.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT